Wow! Is what I thought when I saw this headline, have they really got randomised control trial evidence showing Nox plus Lu better than Lu alone.
then I saw the results are from …..ahem….mice.
ROFL…
Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-7
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.06M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $5.653K | 48.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22101 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 159073 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |